272-23-1 | Thieno[2,3-b]pyridine

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$21.00	$15.00
1g	98%	in stock	$48.00	$34.00
5g	98%	in stock	$233.00	$164.00
10g	98%	in stock	$460.00	$322.00

Description

• Catalog Number: AF61333
• Chemical Name: Thieno[2,3-b]pyridine
• CAS Number: 272-23-1
• Molecular Formula: C7H5NS
• Molecular Weight: 135.1863
• MDL Number: MFCD01631145
• SMILES: c1cnc2c(c1)ccs2
• NSC Number: 152397

Computed Properties

• Complexity: 105
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 9
• Hydrogen Bond Acceptor Count: 2
• XLogP3: 2.2

Literature

• 4-(3-Fluoro-anilino)thieno[2,3-b]pyridine-6-carb-oxy-lic acid.

  Acta crystallographica. Section E, Structure reports online 20120701

• 3-Amino-N-benzyl-6-(4-fluoro-phen-yl)thieno[2,3-b]pyridine-2-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20120601

• Synthesis and pharmacological evaluation of thieno[2,3-b]pyridine derivatives as novel c-Src inhibitors.

  Bioorganic & medicinal chemistry 20110415

• 3-[Bis(p-tolyl-sulfon-yl)amino]-N-(4-chloro-benz-yl)-6-(3,4-dichloro-phen-yl)thieno[2,3-b]pyridine-2-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20110201

• Synthesis of some nucleosides derivatives from L- rhamnose with expected biological activity.

  Chemistry Central journal 20110101

• Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues.

  Bioorganic & medicinal chemistry letters 20100401

• Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.

  Bioorganic & medicinal chemistry 20090701

• Ethyl 3-(4-methyl-benzene-sulfonamido)thieno[2,3-b]pyridine-2-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20090201

• Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.

  Bioorganic & medicinal chemistry 20080901

• Design, synthesis, SAR, and biological evaluation of new 4-(phenylamino)thieno[2,3-b]pyridine derivatives.

  Bioorganic & medicinal chemistry 20060815

• Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.

  Journal of medicinal chemistry 20060629